Legacy Capital Group California’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
1,418
-8,315
-85% -$1.75M 0.1% 253
2025
Q4
$1.93M Buy
9,733
+1,532
+19% +$310K 0.47% 43
2025
Q3
$1.67M Sell
8,201
-72
-0.9% -$12.8K 0.42% 47
2025
Q2
$1.46M Buy
+8,273
New +$1.25M 0.4% 49
2024
Q4
Sell
-6,350
Closed -$1.06M 357
2024
Q3
$1.06M Buy
+6,350
New +$960K 0.35% 64

Other funds holding THC

Legacy Capital Group California's THC Position: Q1 2026 in Review

Legacy Capital Group California reduced its Tenet Healthcare (THC) stake by 85% in Q1 2026, selling an estimated $1.75M and leaving 1,418 shares worth $268K. The position accounts for 0.1% of the portfolio, ranked #253.

Legacy Capital Group California first reported a position in THC in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.93M in Q4 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Legacy Capital Group California held 1,418 shares of Tenet Healthcare worth $268K as of Q1 2026.
  • Legacy Capital Group California sold 8,315 Tenet Healthcare shares in Q1 2026, an estimated $1.75M.
  • Tenet Healthcare made up 0.1% of Legacy Capital Group California's portfolio in Q1 2026, its #253 holding.
  • Legacy Capital Group California first reported a position in Tenet Healthcare in Q3 2024 and has held it in 5 quarters since.
  • Legacy Capital Group California's Tenet Healthcare position peaked at $1.93M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.